Kanaph Therapeutics

0082N0 · KOSDAQ · ₩0082N0 · 카나프테라퓨틱스

₩9,100▼ ₩550 (5.70%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me

Filings

  • Notice on Grant of Stock Purchase Options주식매수선택권부여에관한신고

    Predicted impact: Low

    Oct 22, 2026Open on DART
  • Investor relations (IR) event기업설명회(IR)개최

    Predicted impact: Low· Actual: −8.6% vs sector, volume 4.1× normal (5 trading days)

    Oct 12, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Sep 18, 2026Open on DART
  • Investor relations (IR) event기업설명회(IR)개최Sep 8, 2026Open on DART
  • Half-year report (Jun 2026)반기보고서 (2026.06)Aug 12, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jul 20, 2026Open on DART
  • Notice on Grant of Stock Purchase Options주식매수선택권부여에관한신고May 28, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서May 22, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서May 22, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서May 22, 2026Open on DART
  • Quarterly report (Mar 2026)분기보고서 (2026.03)May 13, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(약식)Apr 23, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Apr 22, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Apr 22, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Apr 22, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Apr 22, 2026Open on DART
  • Annual general meeting results정기주주총회결과Mar 30, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Mar 23, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Mar 23, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Mar 23, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(약식)Mar 23, 2026Open on DART
  • Exercise of Stock Purchase Options주식매수선택권행사Mar 20, 2026Open on DART
  • Audit report submitted감사보고서제출Mar 19, 2026Open on DART
  • Annual report (Dec 2025)사업보고서 (2025.12)Mar 19, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(약식)Mar 19, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(약식)Mar 19, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Mar 17, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Mar 17, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Mar 17, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Mar 17, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Mar 17, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Mar 17, 2026Open on DART
  • Notice of Reason for Concentrated Shareholders' Meeting Date주주총회집중일개최사유신고Mar 16, 2026Open on DART
  • Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Mar 16, 2026Open on DART
  • Notice of shareholders' meeting주주총회소집공고Mar 16, 2026Open on DART
  • Securities Issuance Results Report증권발행실적보고서Mar 10, 2026Open on DART
  • Amended: Prospectus[기재정정]투자설명서Mar 4, 2026Open on DART
  • Terms set: Securities registration statement[발행조건확정]증권신고서(지분증권)Mar 4, 2026Open on DART
  • Prospectus투자설명서Feb 27, 2026Open on DART
  • Amended: Securities registration statement[기재정정]증권신고서(지분증권)Feb 23, 2026Open on DART
  • Amended: Securities registration statement[기재정정]증권신고서(지분증권)Feb 12, 2026Open on DART
  • Amended: Securities registration statement[기재정정]증권신고서(지분증권)Feb 2, 2026Open on DART
  • Amended: Securities registration statement[기재정정]증권신고서(지분증권)Jan 19, 2026Open on DART
  • Securities registration statement증권신고서(지분증권)Jan 5, 2026Open on DART
  • Audit Report (2024.12)감사보고서 (2024.12)Apr 1, 2025Open on DART
  • Audit Report (2023.12)감사보고서 (2023.12)Apr 8, 2024Open on DART

Titles in Korean until English translations are added.

Also known as: Kanaph Therapeutics / 카나프테라퓨틱스 / 0082N0 / KRX:0082N0

Source: KRX statistical information